NAMSA is a leading global CRO specializing in medical device and IVD development, offering comprehensive services from preclinical research to regulatory submissions and market access.
NAMSA is a premier global Contract Research Organization (CRO) dedicated to advancing medical device and In Vitro Diagnostic (IVD) innovation and safety worldwide. With over 50 years of experience, NAMSA supports over 3,000 companies annually, from startups to multinationals, in navigating the complex regulatory landscape. Their extensive expertise covers the entire product lifecycle, including strategic consulting, preclinical research, clinical trials, biological safety testing, and market access. Leveraging a team of 1,400+ professionals across North America, Europe, and Asia, NAMSA provides unparalleled support for regulatory submissions to agencies like the US FDA and EU Notified Bodies. They offer specialized services such as US FDA consulting (510(k), PMA, De Novo), EU MDR & IVDR consulting, biological safety assessments, and market research. Their state-of-the-art, GLP-compliant facilities conduct over 118,000 tests annually, ensuring devices are safe, effective, and compliant with global regulations. NAMSA's integrated approach ensures clients receive tailored solutions, from initial concept to commercialization. They are committed to helping clients shorten time-to-market, reduce costs, and achieve successful product launches by providing deep industry knowledge and client-focused service.
About
**Who they are** NAMSA is a global Contract Research Organization (CRO) focused on medical device and In Vitro Diagnostic (IVD) development. They offer a comprehensive suite of services designed to support clients throughout the entire product lifecycle.
**Expertise & scope** * Specializes in medical device and IVD development. * Services span preclinical research, regulatory submissions, and market access. * Focuses on Usability / Human Factors Engineering.
**Reputation / proof points** * A leading global CRO.
Additional information
NAMSA's approach to Usability / Human Factors Engineering is integrated into the broader medical device development process. They assist clients in navigating complex regulatory landscapes by ensuring that devices are designed with the end-user and intended use environment in mind. This focus on human factors is critical for patient safety and successful market adoption. Buyers can expect a partner that understands the interdependencies between design, usability, and regulatory compliance, aiming to de-risk the development pathway.
Key Highlights
Global CRO specializing in medical device and IVD development.
Source
“NAMSA is a leading global CRO specializing in medical device and IVD development”
Offers comprehensive services from preclinical research to regulatory submissions and market access.
Source
“offering comprehensive services from preclinical research to regulatory submissions and market access.”
Certifications & Trust Signals
Recognized as a leading global CRO in its field.
Source
“NAMSA is a leading global CRO specializing in medical device and IVD development”
Buyer Snapshot
Best for
Medical device and IVD developers
Companies seeking regulatory submission support
Organizations prioritizing device safety and usability
How engagement typically works
Comprehensive service offering
Integrated development support
Typical deliverables
Usability engineering reports
Regulatory submission documentation
Preclinical research data
Good to know
Best when seeking end-to-end support for medical device development.
HQ: United States, US
Languages: English
Timezones: UTC, EST
Claim status: Listed
Services & Capabilities
Usability / Human Factors Testing
Countries: United States, United Kingdom, Switzerland, Canada, Japan, Australia, Brazil, Europe, Asia
Industries: Medical Devices
Pricing model: Custom pricing
Usability Study Types Offered: Formative study, Summative study